American Journal of Clinical Nutrition, Vol 67, 1273-1278, Copyright © 1998 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Biochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake

P Fardellone, M Brazier, S Kamel, J Gueris, AM Graulet, J Lienard and JL Sebert
Department of Rheumatology, CHU, Amiens, France.

We studied the biochemical effects of calcium supplementation during a 2-mo course in postmenopausal women (x +/- SD: 64 +/- 5 y of age and 14.5 +/- 6.7 y since menopause). The effects on calcium homeostasis and bone remodeling were assessed after 1 and 2 mo of daily administration of either calcium carbonate (1200 mg elemental Ca/d, n = 60) or a placebo (n = 56). The daily dietary calcium intake assessed before the beginning of calcium supplementation was 786 mg/d. We found a significant inverse relation between baseline intact parathyroid hormone (iPTH) and dietary calcium intake before supplementation (r = - 0.48, P = 0.0002). A significant increase in urinary excretion of pyridinoline was observed when the dietary calcium intake was lower than the median value. Calcium supplementation resulted in a significant increase in 24-h urinary calcium (39%, P < 0.02) and a significant reduction of bone alkaline phosphatase at 2 mo and of all bone-resorption markers (hydroxyproline, pyridinoline, and deoxypyridinoline) at I and 2 mo without significant changes in 44-68 PTH fragments or iPTH concentrations. When the dietary calcium intake was low (mean +/- SD: 576 +/- 142 mg/d), calcium supplementation was responsible for a greater increase in urinary calcium excretion and a greater decrease in markers of bone turnover. The greatest variations were observed for deoxypyridinoline at 1 and 2 mo (-18.5%, P < 0.05) and for pyridinoline at 1 mo (-16.3%, P < 0.01). Two months of calcium supplementation in postmenopausal women was efficient in reducing markers of bone turnover, with a greater effect in women with a low dietary calcium intake.

This article has been cited by other articles:

				F. Grados, M. Brazier, S. Kamel, M. Mathieu, N. Hurtebize, M. Maamer, M. Garabedian, J.-L. Sebert, and P. Fardellone Prediction of Bone Mass Density Variation by Bone Remodeling Markers in Postmenopausal Women with Vitamin D Insufficiency Treated with Calcium and Vitamin D Supplementation J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5175 - 5179. [Abstract] [Full Text] [PDF]

				A. Zittermann, I. Schwarz, K. Scheld, T. Sudhop, H. K. Berthold, K. von Bergmann, H. van der Ven, and P. Stehle Physiologic Fluctuations of Serum Estradiol Levels Influence Biochemical Markers of Bone Resorption in Young Women J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 95 - 101. [Abstract] [Full Text]

				F. Antoniazzi, F. Bertoldo, S. Lauriola, S. Sirpresi, E. Gasperi, G. Zamboni, and L. Tatò Prevention of Bone Demineralization by Calcium Supplementation in Precocious Puberty during Gonadotropin-Releasing Hormone Agonist Treatment J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1992 - 1996. [Abstract] [Full Text]

				K. M. Prestwood, D. L. Thompson, A. M. Kenny, M. J. Seibel, C. C. Pilbeam, and L. G. Raisz Low Dose Estrogen and Calcium Have an Additive Effect on Bone Resorption in Older Women J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 179 - 183. [Abstract] [Full Text]